WASHINGTON — Entyvio is “safe and effective” for maintaining sustained steroid-free remission at 1 year in children with inflammatory bowel disease, more so in those with ulcerative colitis vs. Crohn’s disease, according to a researcher.
“We know that children with inflammatory bowel disease, compared to adults, can have a more severe disease phenotype that is
/PRNewswire/ The "Enteral Feeding Pumps - Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. Global Enteral.
Parents in the active disease group indicated greater levels of anxiety than parents of children without active IBD, suggesting a correlation between parental mental health and their child’s disease activity.